RECEPTOS
Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.
RECEPTOS
Industry:
Biopharma Biotechnology Health Care
Founded:
2007-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.bms.com
Total Employee:
51+
Status:
Active
Contact:
(858) 652-5700
Email Addresses:
[email protected]
Total Funding:
103.48 M USD
Technology used in webpage:
ASP.NET CSC Global DNS CDNS Network
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Dare Bioscience
Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.
Aderis Pharmaceuticals
Aderis Pharmaceuticals focused on discovery, development and commercialization of products for the diagnosis.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Haemalogix
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
Klotho Therapeutics
Focused on development and commercialization of recombinant human Klotho proteins to prevent and treat kidney disease and other diseases.
Kythera Biopharmaceuticals
Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.
LPATH
Lpat focuses on the discovery and development of monoclonal antibodies that target bioactive lipids.
OncoCell MDx
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
RECEPTA Biopharma
Recepta Biopharma engages in the research, development, production, and commercialization of biopharmaceuticals.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Tavotek Biotherapeutics
Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Flagship Pioneering
Flagship Pioneering investment in Series B - Receptos
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Receptos
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series B - Receptos
Polaris Partners
Polaris Partners investment in Series B - Receptos
Lilly Ventures
Lilly Ventures investment in Series B - Receptos
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Receptos
Lilly Ventures
Lilly Ventures investment in Venture Round - Receptos
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Venture Round - Receptos
OrbiMed
OrbiMed investment in Venture Round - Receptos
Flagship Pioneering
Flagship Pioneering investment in Venture Round - Receptos
Official Site Inspections
http://www.bms.com
- Host name: 45.60.150.161
- IP address: 45.60.150.161
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Receptos"
Global Biopharmaceutical Company - Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.See details»
About us - Bristol Myers Squibb
We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. At Bristol Myers Squibb, we work every day to transform patients’ …See details»
Our leadership team - Bristol Myers Squibb
Meet the executive leaders at Bristol Myers Squibb who are not only responsible for day-to-day operations, but are also innovators in the biotech industry committed to patients, customers, …See details»
Bristol Myers Squibb - Wikipedia
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion. See details»
Org Chart Bristol-Myers Squibb - The Official Board
Download your org chart in Excel • Bristol-Myers Squibb org chart • Bristol-Myers Squibb org chart with its 23 subsidiaries (24 org charts) Print your org chart in PDF • Bristol-Myers Squibb org chartSee details»
Bristol-Myers Squibb - The Org
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.See details»
Annual Report 2023 - Bristol Myers Squibb
We are committed to discovering, developing and delivering transformational medicines in disease areas where we believe we can make a meaningful difference — and we made strong progress in 2023.See details»
Life At BMS - BMS Careers
At Bristol Myers Squibb, you’ll join a diverse, high-achieving team united by a common mission. You’ll grow and thrive through opportunities that are uncommon in scale and scope. You’ll pursue innovative ideas while advancing …See details»
Bristol Myers Squibb - LinkedIn
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience.See details»
Global Product Development and Supply - BMS Careers
Our Global Product Development and Supply (GPS) organization brings hope to our patients around the world through the sustainable development and delivery of high-quality, innovative and life-changing medicines. While our work …See details»
Global Inclusion & Diversity - Bristol Myers Squibb
At Bristol Myers Squibb, our global commitment to inclusion and diversity (GI&D) strengthens our ability to serve the evolving needs of patients and communities, our people, our business and industry. Our value of inclusion defines who we …See details»
Country | Canada - BMS Careers
In Canada, we have three People and Business Resource Groups (PBRGs) to support the business objectives, career advancement and development needs of our employees. These …See details»
Annual Report 2021 - Bristol Myers Squibb
Learn how a single touch can transform patients’ lives in Bristol Myers Squibb’s 2021 Annual Report.See details»
Bristol Myers Squibb - Bristol Myers Squibb Announces Progress …
Mar 15, 2023 · In 2020, Bristol Myers Squibb (BMS) and the Bristol Myers Squibb Foundation, an independent charitable organization, each committed $150 million over five years, totaling …See details»
Bristol Myers Squibb - Bristol Myers Squibb to Participate in Citi’s ...
2 days ago · Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Citi’s 2024 Global Healthcare Conference. Christopher Boerner, Ph.D., board …See details»
2023 ESG Report - Bristol Myers Squibb
Explore Bristol Myers Squibb's 2023 ESG Report to discover our commitment to environmental, social and governance practices. Learn about our progress, initiatives and future sustainability …See details»
People and business resource groups - Bristol Myers Squibb
Learn more about the leaders of the company’s People & Business Resource Groups (PBRGs), who report directly to members of our Leadership Team and act as an advisory group on key …See details»
Press Releases - Bristol Myers Squibb
Media Inquiries: [email protected]. Investor Relations: [email protected]. Subscribe to our RSS feed. Receive updated news from preferred websites, which are sent directly to the …See details»
Nivolumab in Patients With Advanced or Metastatic Malignancies ...
1 day ago · PURPOSETo report on CheckMate 627 (ClinicalTrials.gov identifier: NCT02832167), a phase II adaptive basket design trial of nivolumab in uncommon advanced/metastatic …See details»
Corporate governance and management - Bristol Myers Squibb
Find out about Bristol Myers Squibb's corporate governance, ensuring the company operates in the most reliable, efficient, transparent and ethical manner.See details»